Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.

Autoimmunity - 1 Mar 2014

Gustafsson Johanna T, Svenungsson Elisabet

Abstract excerpt

Patients with systemic lupus erythematosus (SLE) have a significantly increased risk of cardiovascular disease (CVD). Increased prevalence of atherosclerosis may explain part of this enhanced risk, but SLE related CVD can also result from other mechanisms. Vascular events may be the result of several pathophysiologic mechanisms; some can be caused by atherosclerosis, others may be primarily thrombotic, and some...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Antinuclear
Share to Autoimmunity
Share to Cardiovascular Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression

Share to HLA Antigens

Share to Incidence

Share to Inflammation

Share to Lupus Erythematosus, Systemic

Source

Identifiers

PMID: 24228980
DOI: 10.3109/08916934.2013.856005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.PMID 24228980Read ↗

Cardiovascular Consequences of Autoimmune Rheumatic Diseases.Semantic proximity Read ↗

Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune DisordersSemantic proximity Read ↗

Systemic lupus erythematosus-accelerated atherosclerosis: mechanistic insights and clinical implications.Semantic proximity Read ↗

Cardiovascular Involvement in Autoimmune DiseasesSemantic proximity Read ↗

Statins May Not be Associated with a Reduction in Primary Cardiovascular Events in Patients with Systemic Lupus ErythematosusSemantic proximity Read ↗

Cardiovascular Risk in Systemic Lupus Erythematosus: A Cross-Sectional Analysis of NHANES 2001–2023Semantic proximity Read ↗

Atherosclerosis and systemic lupus erythematosus — mechanistic basis of the associationSemantic proximity Read ↗

Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients.Semantic proximity Read ↗

THE STATE OF CURRENT MANAGEMENT OF THE HEIGHTENED RISK FOR ATHEROSCLEROTIC CARDIOVASCULAR EVENTS IN AN ESTABLISHED COHORT OF PATIENTS WITH LUPUS ERYTHEMATOSUSSemantic proximity Read ↗

Identification of crucial genes for predicting the risk of atherosclerosis with system lupus erythematosus based on comprehensive bioinformatics analysis and machine learningSemantic proximity Read ↗

Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus.Semantic proximity Read ↗

Unique monocyte transcriptomic profiles are associated with preclinical atherosclerosis in women with systemic lupus erythematosus (SLE)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.